Pre-order Enquiry
Request Free Sample
Impact of COVID-19 Outbreak on Hepatitis B Vaccine (Recombinant), Global Market Research Report 2020
SKU ID : QYR-15607654 | Publishing Date : 29-Apr-2020 | No. of pages : 97
Detailed TOC of Impact of COVID-19 Outbreak on Hepatitis B Vaccine (Recombinant), Global Market Research Report 2020
1 Hepatitis B Vaccine (Recombinant) Market Overview1.1 Product Overview and Scope of Hepatitis B Vaccine (Recombinant)
1.2 Hepatitis B Vaccine (Recombinant) Segment by Type
1.2.1 Global Hepatitis B Vaccine (Recombinant) Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 10mcg/0.5ml
1.2.3 10mcg/ml
1.3 Hepatitis B Vaccine (Recombinant) Segment by Application
1.3.1 Hepatitis B Vaccine (Recombinant) Sales Comparison by Application: 2020 VS 2026
1.3.2 Newborn
1.3.3 Adult
1.4 Global Hepatitis B Vaccine (Recombinant) Market Size Estimates and Forecasts
1.4.1 Global Hepatitis B Vaccine (Recombinant) Revenue 2015-2026
1.4.2 Global Hepatitis B Vaccine (Recombinant) Sales 2015-2026
1.4.3 Hepatitis B Vaccine (Recombinant) Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Hepatitis B Vaccine (Recombinant) Industry Impact
1.5.1 How the Covid-19 is Affecting the Hepatitis B Vaccine (Recombinant) Industry
1.5.1.1 Hepatitis B Vaccine (Recombinant) Business Impact Assessment - Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Hepatitis B Vaccine (Recombinant) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Hepatitis B Vaccine (Recombinant) Players to Combat Covid-19 Impact
2 Global Hepatitis B Vaccine (Recombinant) Market Competition by Manufacturers
2.1 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Manufacturers (2015-2020)
2.2 Global Hepatitis B Vaccine (Recombinant) Revenue Share by Manufacturers (2015-2020)
2.3 Global Hepatitis B Vaccine (Recombinant) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Hepatitis B Vaccine (Recombinant) Manufacturing Sites, Area Served, Product Type
2.5 Hepatitis B Vaccine (Recombinant) Market Competitive Situation and Trends
2.5.1 Hepatitis B Vaccine (Recombinant) Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Hepatitis B Vaccine (Recombinant) Players (Opinion Leaders)
3 Hepatitis B Vaccine (Recombinant) Retrospective Market Scenario by Region
3.1 Global Hepatitis B Vaccine (Recombinant) Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Hepatitis B Vaccine (Recombinant) Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Hepatitis B Vaccine (Recombinant) Market Facts & Figures by Country
3.3.1 North America Hepatitis B Vaccine (Recombinant) Sales by Country
3.3.2 North America Hepatitis B Vaccine (Recombinant) Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Hepatitis B Vaccine (Recombinant) Market Facts & Figures by Country
3.4.1 Europe Hepatitis B Vaccine (Recombinant) Sales by Country
3.4.2 Europe Hepatitis B Vaccine (Recombinant) Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Hepatitis B Vaccine (Recombinant) Market Facts & Figures by Region
3.5.1 Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Region
3.5.2 Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Hepatitis B Vaccine (Recombinant) Market Facts & Figures by Country
3.6.1 Latin America Hepatitis B Vaccine (Recombinant) Sales by Country
3.6.2 Latin America Hepatitis B Vaccine (Recombinant) Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Facts & Figures by Country
3.7.1 Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Country
3.7.2 Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Hepatitis B Vaccine (Recombinant) Historic Market Analysis by Type
4.1 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2015-2020)
4.2 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Type (2015-2020)
4.3 Global Hepatitis B Vaccine (Recombinant) Price Market Share by Type (2015-2020)
4.4 Global Hepatitis B Vaccine (Recombinant) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Hepatitis B Vaccine (Recombinant) Historic Market Analysis by Application
5.1 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2015-2020)
5.2 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Application (2015-2020)
5.3 Global Hepatitis B Vaccine (Recombinant) Price by Application (2015-2020)
6 Company Profiles and Key Figures in Hepatitis B Vaccine (Recombinant) Business
6.1 GSK
6.1.1 Corporation Information
6.1.2 GSK Description, Business Overview and Total Revenue
6.1.3 GSK Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2015-2020)
6.1.4 GSK Products Offered
6.1.5 GSK Recent Development
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description, Business Overview and Total Revenue
6.2.3 Merck Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Merck Products Offered
6.2.5 Merck Recent Development
6.3 Sanofi Pasteur
6.3.1 Sanofi Pasteur Corporation Information
6.3.2 Sanofi Pasteur Description, Business Overview and Total Revenue
6.3.3 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Sanofi Pasteur Products Offered
6.3.5 Sanofi Pasteur Recent Development
6.4 Dynavax Technologies
6.4.1 Dynavax Technologies Corporation Information
6.4.2 Dynavax Technologies Description, Business Overview and Total Revenue
6.4.3 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Dynavax Technologies Products Offered
6.4.5 Dynavax Technologies Recent Development
6.5 LG Life Sciences
6.5.1 LG Life Sciences Corporation Information
6.5.2 LG Life Sciences Description, Business Overview and Total Revenue
6.5.3 LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2015-2020)
6.5.4 LG Life Sciences Products Offered
6.5.5 LG Life Sciences Recent Development
6.6 KM Biologics
6.6.1 KM Biologics Corporation Information
6.6.2 KM Biologics Description, Business Overview and Total Revenue
6.6.3 KM Biologics Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2015-2020)
6.6.4 KM Biologics Products Offered
6.6.5 KM Biologics Recent Development
6.7 Shenzhen Kangtai Biological Products
6.6.1 Shenzhen Kangtai Biological Products Corporation Information
6.6.2 Shenzhen Kangtai Biological Products Description, Business Overview and Total Revenue
6.6.3 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Shenzhen Kangtai Biological Products Products Offered
6.7.5 Shenzhen Kangtai Biological Products Recent Development
6.8 Serum Institute
6.8.1 Serum Institute Corporation Information
6.8.2 Serum Institute Description, Business Overview and Total Revenue
6.8.3 Serum Institute Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Serum Institute Products Offered
6.8.5 Serum Institute Recent Development
7 Hepatitis B Vaccine (Recombinant) Manufacturing Cost Analysis
7.1 Hepatitis B Vaccine (Recombinant) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Hepatitis B Vaccine (Recombinant)
7.4 Hepatitis B Vaccine (Recombinant) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Hepatitis B Vaccine (Recombinant) Distributors List
8.3 Hepatitis B Vaccine (Recombinant) Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Hepatitis B Vaccine (Recombinant) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Hepatitis B Vaccine (Recombinant) by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Hepatitis B Vaccine (Recombinant) by Type (2021-2026)
10.2 Hepatitis B Vaccine (Recombinant) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Hepatitis B Vaccine (Recombinant) by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Hepatitis B Vaccine (Recombinant) by Application (2021-2026)
10.3 Hepatitis B Vaccine (Recombinant) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Hepatitis B Vaccine (Recombinant) by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Hepatitis B Vaccine (Recombinant) by Region (2021-2026)
10.4 North America Hepatitis B Vaccine (Recombinant) Estimates and Projections (2021-2026)
10.5 Europe Hepatitis B Vaccine (Recombinant) Estimates and Projections (2021-2026)
10.6 Asia Pacific Hepatitis B Vaccine (Recombinant) Estimates and Projections (2021-2026)
10.7 Latin America Hepatitis B Vaccine (Recombinant) Estimates and Projections (2021-2026)
10.8 Middle East and Africa Hepatitis B Vaccine (Recombinant) Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Impact of COVID-19 Outbreak on Hepatitis B Vaccine (Recombinant), Global Market Research Report 2020
List of TablesTable 1. Global Hepatitis B Vaccine (Recombinant) Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Hepatitis B Vaccine (Recombinant) Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Hepatitis B Vaccine (Recombinant) Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four Hepatitis B Vaccine (Recombinant) Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Hepatitis B Vaccine (Recombinant) Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Hepatitis B Vaccine (Recombinant) Players to Combat Covid-19 Impact
Table 9. Global Key Hepatitis B Vaccine (Recombinant) Manufacturers Covered in This Study
Table 10. Global Hepatitis B Vaccine (Recombinant) Sales (K Units) by Manufacturers (2015-2020)
Table 11. Global Hepatitis B Vaccine (Recombinant) Sales Share by Manufacturers (2015-2020)
Table 12. Global Hepatitis B Vaccine (Recombinant) Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Hepatitis B Vaccine (Recombinant) Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market Hepatitis B Vaccine (Recombinant) Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 15. Manufacturers Hepatitis B Vaccine (Recombinant) Sales Sites and Area Served
Table 16. Manufacturers Hepatitis B Vaccine (Recombinant) Product Types
Table 17. Global Hepatitis B Vaccine (Recombinant) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Hepatitis B Vaccine (Recombinant) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Vaccine (Recombinant) as of 2019)
Table 19.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key Hepatitis B Vaccine (Recombinant) Players
Table 21. Global Hepatitis B Vaccine (Recombinant) Sales (K Units) by Region (2015-2020)
Table 22. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Region (2015-2020)
Table 23. Global Hepatitis B Vaccine (Recombinant) Revenue (Million US$) by Region (2015-2020)
Table 24. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Region (2015-2020)
Table 25. North America Hepatitis B Vaccine (Recombinant) Sales by Country (2015-2020) (K Units)
Table 26. North America Hepatitis B Vaccine (Recombinant) Sales Market Share by Country (2015-2020)
Table 27. North America Hepatitis B Vaccine (Recombinant) Revenue by Country (2015-2020) (US$ Million)
Table 28. North America Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country (2015-2020)
Table 29. Europe Hepatitis B Vaccine (Recombinant) Sales by Country (2015-2020) (K Units)
Table 30. Europe Hepatitis B Vaccine (Recombinant) Sales Market Share by Country (2015-2020)
Table 31. Europe Hepatitis B Vaccine (Recombinant) Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Region (2015-2020) (K Units)
Table 34. Asia Pacific Hepatitis B Vaccine (Recombinant) Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue Market Share by Region (2015-2020)
Table 37. Latin America Hepatitis B Vaccine (Recombinant) Sales by Country (2015-2020) (K Units)
Table 38. Latin America Hepatitis B Vaccine (Recombinant) Sales Market Share by Country (2015-2020)
Table 39. Latin America Hepatitis B Vaccine (Recombinant) Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Country (2015-2020) (K Units)
Table 42. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country (2015-2020)
Table 45. Global Hepatitis B Vaccine (Recombinant) Sales (K Units) by Type (2015-2020)
Table 46. Global Hepatitis B Vaccine (Recombinant) Sales Share by Type (2015-2020)
Table 47. Global Hepatitis B Vaccine (Recombinant) Revenue (Million US$) by Type (2015-2020)
Table 48. Global Hepatitis B Vaccine (Recombinant) Revenue Share by Type (2015-2020)
Table 49. Global Hepatitis B Vaccine (Recombinant) Price (US$/Unit) by Type (2015-2020)
Table 50. Global Hepatitis B Vaccine (Recombinant) Sales (K Units) by Application (2015-2020)
Table 51. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2015-2020)
Table 52. Global Hepatitis B Vaccine (Recombinant) Sales Growth Rate by Application (2015-2020)
Table 53. GSK Hepatitis B Vaccine (Recombinant) Corporation Information
Table 54. GSK Description and Business Overview
Table 55. GSK Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. GSK Main Product
Table 57. GSK Recent Development
Table 58. Merck Hepatitis B Vaccine (Recombinant) Corporation Information
Table 59. Merck Corporation Information
Table 60. Merck Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Merck Main Product
Table 62. Merck Recent Development
Table 63. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Corporation Information
Table 64. Sanofi Pasteur Corporation Information
Table 65. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Sanofi Pasteur Main Product
Table 67. Sanofi Pasteur Recent Development
Table 68. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Corporation Information
Table 69. Dynavax Technologies Corporation Information
Table 70. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Dynavax Technologies Main Product
Table 72. Dynavax Technologies Recent Development
Table 73. LG Life Sciences Hepatitis B Vaccine (Recombinant) Corporation Information
Table 74. LG Life Sciences Corporation Information
Table 75. LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. LG Life Sciences Main Product
Table 77. LG Life Sciences Recent Development
Table 78. KM Biologics Hepatitis B Vaccine (Recombinant) Corporation Information
Table 79. KM Biologics Corporation Information
Table 80. KM Biologics Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. KM Biologics Main Product
Table 82. KM Biologics Recent Development
Table 83. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Corporation Information
Table 84. Shenzhen Kangtai Biological Products Corporation Information
Table 85. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. Shenzhen Kangtai Biological Products Main Product
Table 87. Shenzhen Kangtai Biological Products Recent Development
Table 88. Serum Institute Hepatitis B Vaccine (Recombinant) Corporation Information
Table 89. Serum Institute Corporation Information
Table 90. Serum Institute Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Serum Institute Main Product
Table 92. Serum Institute Recent Development
Table 93. Sales Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Hepatitis B Vaccine (Recombinant) Distributors List
Table 96. Hepatitis B Vaccine (Recombinant) Customers List
Table 97. Market Key Trends
Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 99. Key Challenges
Table 100. Global Hepatitis B Vaccine (Recombinant) Sales (K Units) Forecast by Type (2021-2026)
Table 101. Global Hepatitis B Vaccine (Recombinant) Sales Market Share Forecast by Type (2021-2026)
Table 102. Global Hepatitis B Vaccine (Recombinant) Revenue (Million US$) Forecast by Type (2021-2026)
Table 103. Global Hepatitis B Vaccine (Recombinant) Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 104. Global Hepatitis B Vaccine (Recombinant) Sales (K Units) Forecast by Application (2021-2026)
Table 105. Global Hepatitis B Vaccine (Recombinant) Revenue (Million US$) Forecast by Application (2021-2026)
Table 106. Global Hepatitis B Vaccine (Recombinant) Sales (K Units) Forecast by Region (2021-2026)
Table 107. Global Hepatitis B Vaccine (Recombinant) Sales Market Share Forecast by Region (2021-2026)
Table 108. Global Hepatitis B Vaccine (Recombinant) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share Forecast by Region (2021-2026)
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Hepatitis B Vaccine (Recombinant)
Figure 2. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type: 2020 VS 2026
Figure 3. 10mcg/0.5ml Product Picture
Figure 4. 10mcg/ml Product Picture
Figure 5. Global Hepatitis B Vaccine (Recombinant) Consumption Market Share by Application: 2020 VS 2026
Figure 6. Newborn
Figure 7. Adult
Figure 8. Global Hepatitis B Vaccine (Recombinant) Market Size 2015-2026 (US$ Million)
Figure 9. Global Hepatitis B Vaccine (Recombinant) Sales Capacity (K Units) (2015-2026)
Figure 10. Global Hepatitis B Vaccine (Recombinant) Market Size Market Share by Region: 2020 Versus 2026
Figure 11. Hepatitis B Vaccine (Recombinant) Sales Share by Manufacturers in 2020
Figure 12. Global Hepatitis B Vaccine (Recombinant) Revenue Share by Manufacturers in 2019
Figure 13. The Global 5 and 10 Largest Players: Market Share by Hepatitis B Vaccine (Recombinant) Revenue in 2019
Figure 14. Hepatitis B Vaccine (Recombinant) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Region (2015-2020)
Figure 16. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Region in 2019
Figure 17. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Region (2015-2020)
Figure 18. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Region in 2019
Figure 19. North America Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2019
Figure 20. North America Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country in 2019
Figure 21. U.S. Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 22. U.S. Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 23. Canada Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 24. Canada Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Europe Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2019
Figure 26. Europe Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country in 2019
Figure 27. Germany Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 28. Germany Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. France Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 30. France Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. U.K. Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 32. U.K. Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Italy Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 34. Italy Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Russia Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 36. Russia Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Asia Pacific Hepatitis B Vaccine (Recombinant) Sales Market Share by Region in 2019
Figure 38. Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue Market Share by Region in 2019
Figure 39. China Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 40. China Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Japan Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 42. Japan Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. South Korea Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 44. South Korea Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. India Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 46. India Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Australia Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 48. Australia Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Taiwan Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 50. Taiwan Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Indonesia Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 52. Indonesia Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Thailand Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 54. Thailand Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Malaysia Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 56. Malaysia Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Philippines Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 58. Philippines Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Vietnam Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 60. Vietnam Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Latin America Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2019
Figure 62. Latin America Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country in 2019
Figure 63. Mexico Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 64. Mexico Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Brazil Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 66. Brazil Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Argentina Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 68. Argentina Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2019
Figure 70. Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country in 2019
Figure 71. Turkey Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 72. Turkey Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Saudi Arabia Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 74. Saudi Arabia Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. UAE Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2015-2020) (K Units)
Figure 76. UAE Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Sales Market Share of Hepatitis B Vaccine (Recombinant) by Type (2015-2020)
Figure 78. Sales Market Share of Hepatitis B Vaccine (Recombinant) by Type in 2019
Figure 79. Revenue Share of Hepatitis B Vaccine (Recombinant) by Type (2015-2020)
Figure 80. Revenue Market Share of Hepatitis B Vaccine (Recombinant) by Type in 2019
Figure 81. Global Hepatitis B Vaccine (Recombinant) Sales Growth by Type (2015-2020) (K Units)
Figure 82. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2015-2020)
Figure 83. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application in 2019
Figure 84. Global Revenue Share of Hepatitis B Vaccine (Recombinant) by Application (2015-2020)
Figure 85. Global Revenue Share of Hepatitis B Vaccine (Recombinant) by Application in 2020
Figure 86. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Dynavax Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. LG Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. KM Biologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Shenzhen Kangtai Biological Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Serum Institute Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Price Trend of Key Raw Materials
Figure 95. Manufacturing Cost Structure of Hepatitis B Vaccine (Recombinant)
Figure 96. Manufacturing Process Analysis of Hepatitis B Vaccine (Recombinant)
Figure 97. Hepatitis B Vaccine (Recombinant) Industrial Chain Analysis
Figure 98. Channels of Distribution
Figure 99. Distributors Profiles
Figure 100. Porter's Five Forces Analysis
Figure 101. North America Hepatitis B Vaccine (Recombinant) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 102. North America Hepatitis B Vaccine (Recombinant) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 103. Europe Hepatitis B Vaccine (Recombinant) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 104. Europe Hepatitis B Vaccine (Recombinant) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 105. Latin America Hepatitis B Vaccine (Recombinant) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 106. Latin America Hepatitis B Vaccine (Recombinant) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Asia Pacific Hepatitis B Vaccine (Recombinant) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Bottom-up and Top-down Approaches for This Report
Figure 112. Data Triangulation
Figure 113. Key Executives Interviewed
Keyplayers in Impact of COVID-19 Outbreak on Hepatitis B Vaccine (Recombinant), Global Market Research Report 2020
GSKMerck
Sanofi Pasteur
Dynavax Technologies
LG Life Sciences
KM Biologics
Shenzhen Kangtai Biological Products
Serum Institute
Request Sample
Request Discount
